conclusions we suggest avoiding the use of tamoxifen for eps in patients with superimposed calciphylaxis. introduction encapsulating peritoneal sclerosis (eps) is a rare but devastating complication of peritoneal dialysis (pd). tamoxifen has been generally well-tolerated, even without randomized controlled trials. case presentation herein, we report a case of a patient undergoing 12 years of pd...

conclusions despite advances in radiological techniques, the exact diagnosis in many cases is still made according to intraoperative findings and histopathological properties of the excised membrane. while some cases of sep remain asymptomatic for years, most cases are characterized by recurrent bouts of acute, subacute or chronic intestinal obstruction. to our knowledge, the case presented her...

encapsulating peritoneal sclerosis (eps) is a rare, acquired condition that has been described interchangeablywith peritoneal encapsulation (pe) as well as abdominal cocoon. eps causes complications for peritoneal dialysis (pd) patients. in eps, the small intestine is covered by a fibrotic and inflammatory peritoneal capsule that either partially or completely encases the bowel. for eps, there ...

Encapsulating peritoneal sclerosis is a rare, but potentially lethal, complication of peritoneal dialysis. Treatment of patients with encapsulating peritoneal sclerosis is controversial. Conservative treatment carries a poor outcome, and immunosuppressive drugs are now used frequently. Most commonly, these immunosuppressive regimens include steroids with or without azathioprine or cyclosporine....

OBJECTIVES Encapsulating peritoneal sclerosis is a rare but serious complication in patients undergoing peritoneal dialysis. Its mortality rate is approximately 30%, despite treatment with total parenteral nutrition, surgery, tamoxifen, or immunosuppressants. MATERIALS AND METHODS Of 991 kidney transplants performed at our institution over 9 years, 50 patients were treated for chronic periton...

Encapsulating peritoneal sclerosis (EPS) is a rare but potentially lethal complication of peritoneal dialysis (PD). Peritoneal tuberculosis is considered an etiologic factor. We report a case of EPS in a 40-year-old man who was switched to hemodialysis because of peritoneal tuberculosis after 2 years of PD. Because of the persistence of gastrointestinal symptoms and cachexia, laparoscopic explo...

Chronic peritoneal dialysis (PD) can be complicated by encapsulating peritoneal sclerosis (EPS), a rare but the most severe complication associated with long-term PD. Morbidity and mortality are still high (range from 25% to 55%) especially in the first year after diagnosis. The international Society for Peritoneal Dialysis (ISPD) defined EPS by clinical signs of abdominal pain, bowel obstructi...